ABCL
Price
$3.04
Change
-$0.10 (-3.18%)
Updated
Feb 21, 04:59 PM (EDT)
Capitalization
897.91M
6 days until earnings call
EDIT
Price
$1.92
Change
-$0.15 (-7.28%)
Updated
Feb 21, 04:59 PM (EDT)
Capitalization
158.49M
5 days until earnings call
Ad is loading...

ABCL vs EDIT

Header iconABCL vs EDIT Comparison
Open Charts ABCL vs EDITBanner chart's image
AbCellera Biologics
Price$3.04
Change-$0.10 (-3.18%)
Volume$10.61K
Capitalization897.91M
Editas Medicine
Price$1.92
Change-$0.15 (-7.28%)
Volume$40.96K
Capitalization158.49M
ABCL vs EDIT Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. EDIT commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and EDIT is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (ABCL: $3.14 vs. EDIT: $2.06)
Brand notoriety: ABCL and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 93% vs. EDIT: 398%
Market capitalization -- ABCL: $897.91M vs. EDIT: $158.49M
ABCL [@Biotechnology] is valued at $897.91M. EDIT’s [@Biotechnology] market capitalization is $158.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileEDIT’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • EDIT’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABCL and EDIT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while EDIT’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 4 bearish.
  • EDIT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than EDIT.

Price Growth

ABCL (@Biotechnology) experienced а 0.00% price change this week, while EDIT (@Biotechnology) price change was +67.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +3.11%.

Reported Earning Dates

ABCL is expected to report earnings on May 13, 2025.

EDIT is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($898M) has a higher market cap than EDIT($158M). EDIT YTD gains are higher at: 62.205 vs. ABCL (7.167). ABCL has higher annual earnings (EBITDA): -202.4M vs. EDIT (-222.63M). ABCL has more cash in the bank: 643M vs. EDIT (265M). EDIT has less debt than ABCL: EDIT (38.5M) vs ABCL (71.4M). EDIT has higher revenues than ABCL: EDIT (61.8M) vs ABCL (33M).
ABCLEDITABCL / EDIT
Capitalization898M158M568%
EBITDA-202.4M-222.63M91%
Gain YTD7.16762.20512%
P/E RatioN/AN/A-
Revenue33M61.8M53%
Total Cash643M265M243%
Total Debt71.4M38.5M185%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLEDIT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BCLPX8.48N/A
N/A
BlackRock Event Driven Equity Inv C
CAMYX27.67N/A
N/A
Cambiar International Equity Instl
OAYEX19.26N/A
N/A
Oakmark International Small Cap Advisor
GMAPX28.59N/A
N/A
Goldman Sachs Small Cap Eq Insghts P
SBQUX12.91N/A
N/A
DSS AmericaFirst Large Cap Shr Buyback U

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with VCYT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-9.51%
VCYT - ABCL
56%
Loosely correlated
-2.52%
CRSP - ABCL
54%
Loosely correlated
-4.88%
NTLA - ABCL
53%
Loosely correlated
-0.24%
PRME - ABCL
53%
Loosely correlated
-4.72%
BEAM - ABCL
52%
Loosely correlated
-2.79%
More

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with NTLA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-35.63%
NTLA - EDIT
62%
Loosely correlated
-0.24%
CRSP - EDIT
60%
Loosely correlated
-4.88%
AXON - EDIT
52%
Loosely correlated
-8.70%
VCYT - EDIT
49%
Loosely correlated
-2.52%
ABCL - EDIT
47%
Loosely correlated
-9.51%
More